Xeltis AG - Product Pipeline Analysis, 2018 Update

Xeltis AG - Product Pipeline Analysis, 2018 Update


  • Products Id :- GDME357711PD
  • |
  • Pages: 26
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Xeltis AG (Xeltis) is a clinical-stage medical equipment company that harnesses advances in science to improve the treatment of heart valve related conditions. The company's polymer-based technology platform, RestoreX, facilitates the natural restoration of heart valve through a process referred to as endogenous tissue restoration (ETR). Based on supramolecular chemistry, the company develops bioabsorbable synthetic heart valves and vascular grafts to replace defective heart valves and blood vessels. ETR enables the patient's natural healing system to develop tissue that spreads into the heart valve of Xeltis, building a new and natural valve inside with full functionality. The implants of Xeltis get absorbed by the body in the course of time. The company also operates research and development centers, manufacturing facility in Eindhoven, the Netherlands. Xeltis is headquartered in Zurich, Switzerland.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Xeltis AG

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Xeltis AG Company Overview 4

Xeltis AG Company Snapshot 4

Xeltis AG Pipeline Products and Ongoing Clinical Trials Overview 4

Xeltis AG-Pipeline Analysis Overview 6

Xeltis AG-Key Facts 6

Xeltis AG-Major Products and Services 7

Xeltis AG Pipeline Products by Development Stage 8

Xeltis AG Ongoing Clinical Trials by Trial Status 10

Xeltis AG Pipeline Products Overview 12

Endogenous Tissue Restoration (ETR) Cardiovascular Graft 12

Endogenous Tissue Restoration (ETR) Cardiovascular Graft Product Overview 12

Transcatheter Aortic Heart Valve 13

Transcatheter Aortic Heart Valve Product Overview 13

Xeltis Pulmonary Valve 14

Xeltis Pulmonary Valve Product Overview 14

Xeltis Pulmonary Valve Clinical Trial 15

Xeltis AG-Key Competitors 17

Xeltis AG-Key Employees 18

Xeltis AG-Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Recent Developments 20

Xeltis AG, Recent Developments 20

Jun 25, 2018: The Children's Hospital of Pittsburgh of UPMC joins the Xplore-2 trial 20

Jun 22, 2018: Children's Hospital Los Angeles joins the Xplore-2 Study 20

Jun 13, 2018: Xeltis restorative technology for aortic valves at ISMICS 20

Jun 01, 2018: Preliminary Xplore-1 data show promise at ECHSA 20

May 30, 2018: Preliminary Xplore-1 data at ECHSA 21

May 22, 2018: Xeltis aortic valve program in focus at EuroPCR 21

May 14, 2018: Xeltis' restorative technology at ICTEHV 21

Apr 13, 2018: Xeltis' restorative aortic valves show promise at HVS 21

Apr 06, 2018: Xeltis' restorative aortic valves at HVS 22

Nov 01, 2017: Xeltis' Aortic Valve Preclinical Results Shared at TCT 2017 22

Appendix 23

Methodology 23

About GlobalData 26

Contact Us 26

Disclaimer 26

List of Figures

Xeltis AG Pipeline Products by Equipment Type 5

Xeltis AG Pipeline Products by Development Stage 8

Xeltis AG Ongoing Clinical Trials by Trial Status 10

List of Tables

Xeltis AG Pipeline Products and Ongoing Clinical Trials Overview 4

Xeltis AG Pipeline Products by Equipment Type 5

Xeltis AG Pipeline Products by Indication 5

Xeltis AG Ongoing Clinical Trials by Trial Status 5

Xeltis AG, Key Facts 6

Xeltis AG, Major Products and Services 7

Xeltis AG Number of Pipeline Products by Development Stage 8

Xeltis AG Pipeline Products Summary by Development Stage 9

Xeltis AG Ongoing Clinical Trials by Trial Status 10

Xeltis AG Ongoing Clinical Trials Summary 11

Endogenous Tissue Restoration (ETR) Cardiovascular Graft-Product Status 12

Endogenous Tissue Restoration (ETR) Cardiovascular Graft-Product Description 12

Transcatheter Aortic Heart Valve-Product Status 13

Transcatheter Aortic Heart Valve-Product Description 13

Xeltis Pulmonary Valve-Product Status 14

Xeltis Pulmonary Valve-Product Description 14

Xeltis Pulmonary Valve-Initial Safety and Performance of the COR-VP-001 Vascular Patch in Pediatric Patients Undergoing Bidirectional Cava-pulmonary Anastomosis 15

Xeltis Pulmonary Valve-Prospective, Non-randomized, Open Label Clinical Study to Assess the Feasibility of the Bioabsorbable Pulmonary Valved Conduit in Subjects Undergoing Right Ventricular Outflow Tract (RVOT) Reconstruction 15

Xeltis Pulmonary Valve-Prospective, Non-randomized, Open Label Clinical Study to Assess the Safety and Performance of the Bioabsorbable Pulmonary Valved Conduit in Subjects Undergoing Right Ventricular Outflow Tract (RVOT) Reconstruction 15

Xeltis Pulmonary Valve-Prospective, Non-randomized, Open Label Clinical Study to Assess the Safety of the Bioabsorbable Pulmonary Valved Conduit (PV-001) in Subjects Undergoing Right Ventricular Outflow Tract (RVOT) Reconstruction 16

Xeltis AG, Key Employees 18

Xeltis AG, Subsidiaries 19

Glossary 25

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Abionic SA

Sequana Medical AG

Symetis SA

Xeltis AG,Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license
Single User License
USD 750 INR 53235
Site License
USD 1500 INR 106470
Corporate User License
USD 2250 INR 159705

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com